David H. Bollinger

Array ( [id] => 4411774 [patent_doc_number] => 06300491 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Oligonucleotide inhibition of cell adhesion' [patent_app_type] => 1 [patent_app_number] => 9/009490 [patent_app_country] => US [patent_app_date] => 1998-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 16 [patent_no_of_words] => 21731 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300491.pdf [firstpage_image] =>[orig_patent_app_number] => 009490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4130416 [patent_doc_number] => 06121046 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Synthetic antisense oligodeoxynucleotides targeted to human ache' [patent_app_type] => 1 [patent_app_number] => 8/990065 [patent_app_country] => US [patent_app_date] => 1997-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20683 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121046.pdf [firstpage_image] =>[orig_patent_app_number] => 990065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311378 [patent_doc_number] => 06610478 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Phenotypic conversion of cells mediated by external guide sequences' [patent_app_type] => B1 [patent_app_number] => 08/912378 [patent_app_country] => US [patent_app_date] => 1997-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 17309 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610478.pdf [firstpage_image] =>[orig_patent_app_number] => 08912378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4213793 [patent_doc_number] => 06110742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Synthetic antisense oligodeoxynucleotides targeted to AChE' [patent_app_type] => 1 [patent_app_number] => 8/850347 [patent_app_country] => US [patent_app_date] => 1997-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 16586 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110742.pdf [firstpage_image] =>[orig_patent_app_number] => 850347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1451381 [patent_doc_number] => 06455689 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Antisense-oligonucleotides for transforming growth factor- (TGF-)' [patent_app_type] => B1 [patent_app_number] => 08/535249 [patent_app_country] => US [patent_app_date] => 1995-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 7621 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455689.pdf [firstpage_image] =>[orig_patent_app_number] => 08535249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4060701 [patent_doc_number] => 05866329 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Method and probe for detection of gene associated with liver neoplastic disease' [patent_app_type] => 1 [patent_app_number] => 8/533996 [patent_app_country] => US [patent_app_date] => 1995-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6794 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866329.pdf [firstpage_image] =>[orig_patent_app_number] => 533996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 988261 [patent_doc_number] => 06921816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-26 [patent_title] => 'Chimerical peptide-nucleic acid fragment, process for producing the same and its for appropriately introducing nucleic acids into cell organelles and cells' [patent_app_type] => utility [patent_app_number] => 08/765244 [patent_app_country] => US [patent_app_date] => 1995-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 19 [patent_no_of_words] => 11362 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/921/06921816.pdf [firstpage_image] =>[orig_patent_app_number] => 08765244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209671 [patent_doc_number] => 06713456 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Nucleozymes' [patent_app_type] => B1 [patent_app_number] => 08/459340 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6623 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713456.pdf [firstpage_image] =>[orig_patent_app_number] => 08459340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4370342 [patent_doc_number] => 06288030 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Stem cell factor formulations and methods' [patent_app_type] => 1 [patent_app_number] => 8/172507 [patent_app_country] => US [patent_app_date] => 1993-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6060 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288030.pdf [firstpage_image] =>[orig_patent_app_number] => 172507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1597085 [patent_doc_number] => 06492512 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Method and reagent for treatment of lung cancer and other malignancies caused by the deregulation of L-MYC gene expression' [patent_app_type] => B1 [patent_app_number] => 07/936532 [patent_app_country] => US [patent_app_date] => 1992-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8882 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492512.pdf [firstpage_image] =>[orig_patent_app_number] => 07936532 [rel_patent_id] =>[rel_patent_doc_number] =>)